Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman
-
Upload
health-sciences-north-horizon-sante-nord -
Category
Health & Medicine
-
view
474 -
download
1
description
Transcript of Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman
![Page 1: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/1.jpg)
The Case for Action
Colorectal Cancer in the Northeast
Mark Hartman Vice President Cancer Services and Medical Imaging, HSN;
Regional Vice President Northeast, Cancer Care Ontario
![Page 2: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/2.jpg)
Faculty/Presenter Disclosure
Faculty: Mark Hartman
Relationships with commercial interests:•Grants/Research Support: None•Speakers Bureau/Honoraria: None•Consulting Fees: None
![Page 3: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/3.jpg)
The Colorectal Cancer Burden
Incidence: 2nd in NE
Data source: Cancer Care Ontario (Ontario Cancer Registry, 2010 for SEER*Stat Release 8 Feb. 2011).
![Page 4: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/4.jpg)
The Colorectal Cancer Burden
Deaths: 2nd in NE
Data source: Cancer Care Ontario (Ontario Cancer Registry, 2010 for SEER*Stat Release 8 Feb. 2011).
![Page 5: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/5.jpg)
The Northeast
Highest Incidence in Ontario
55 vs 47.7 per 100,000
474 New Cases
180 Deaths
![Page 6: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/6.jpg)
Stage at Diagnosis: An Opportunity
I
II
III
IV
50%
Estimated 5 yr
relative survival
5%
55%
96%
87%
![Page 7: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/7.jpg)
Colorectal Screening
45%25%
![Page 8: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/8.jpg)
Screening Follow Up
+ve FOBT(n=955) Colonoscopy(n=701)
27% no colonoscopy
within 6mo
![Page 9: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/9.jpg)
Diagnosis in the Northeast
Pathology Turnaround Time:
85% with 2 weeks
FOBT +ve Colonoscopy:
81% within 8 weeks
+ve Family Hx Colonoscopy:
86% within 26 weeks
![Page 10: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/10.jpg)
Radiation Treatment
![Page 11: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/11.jpg)
Systemic Treatment
89%
![Page 12: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/12.jpg)
Surgery and Pathology
<10%
![Page 13: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/13.jpg)
Outcomes
NE=65%
![Page 14: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/14.jpg)
Outcomes
![Page 15: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/15.jpg)
Prevalence
NE~2550
![Page 16: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/16.jpg)
Patient Experience
42%
![Page 17: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/17.jpg)
Summary
Foundational systems are in place
Standards are being established
Progress is being made
Many opportunities for improved outcomes and experiences
![Page 18: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman](https://reader035.fdocuments.net/reader035/viewer/2022062514/558bcb05d8b42aeb6f8b458c/html5/thumbnails/18.jpg)
References
• Cancer System Quality Index 2013: http://www.csqi.on.ca/cms/One.aspx?portalId=258922&pageId=274113
• INSIGHT ON COLORECTAL CANCER: News and information on colorectal cancer and screening in Ontario, volume seven, December 2008, Cancer Care Ontario
• ColonCancerCheck Program Report 2010, https://www.cancercare.on.ca/cms/One.aspx?portalId=1377&pageId=226298
• Cancer Statistics 2007, Cancer Care Ontario, https://www.cancercare.on.ca/cms/One.aspx?portalId=1377&pageId=8630